
Astellas' Iveric takeover rewarded with FDA nod for GA drug
The FDA has approved a new drug for sight-robbing disease geographic atrophy from Astellas, just a few weeks after the company
Newsletters and Deep Dive digital magazine
The FDA has approved a new drug for sight-robbing disease geographic atrophy from Astellas, just a few weeks after the company
Biogen and Sage Therapeutics' zuranolone has become the first oral drug to be approved by the FDA for post-partum depression (PPD), but the US regulator turned down a requ
The final obstacle to the routine use of Sanofi and AstraZeneca's Beyfortus to prevent respiratory syncytial virus (RSV) in the US has fallen after it was backed by Centre
Gene sequencing specialist PacBio has reached an agreement to buy Apton Biosystems, boosting its position in short-read sequencing technology that has traditionally been d
Research has shown that vaccine hesitancy is on the rise globally.
Editor's Picks
Newsletters and Deep Dive
digital magazine